Cynthia Kendall Hahn, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Hemoglobin | 2 | 2014 | 346 | 0.730 |
Why?
|
Eukaryotic Initiation Factor-2 | 2 | 2014 | 178 | 0.500 |
Why?
|
gamma-Globins | 1 | 2014 | 105 | 0.440 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1434 | 0.430 |
Why?
|
Erythroid Cells | 1 | 2014 | 237 | 0.410 |
Why?
|
Protein Biosynthesis | 2 | 2014 | 2094 | 0.340 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2024 | 1641 | 0.300 |
Why?
|
Retinoids | 1 | 2008 | 99 | 0.290 |
Why?
|
Thiourea | 2 | 2014 | 68 | 0.220 |
Why?
|
Cinnamates | 2 | 2014 | 59 | 0.220 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2008 | 776 | 0.210 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1331 | 0.210 |
Why?
|
Cell Differentiation | 4 | 2012 | 11648 | 0.200 |
Why?
|
K562 Cells | 2 | 2014 | 645 | 0.200 |
Why?
|
Vincristine | 1 | 2023 | 1039 | 0.180 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2426 | 0.170 |
Why?
|
Neuroblastoma | 1 | 2008 | 1266 | 0.170 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2884 | 0.160 |
Why?
|
Prednisone | 1 | 2023 | 1566 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 242 | 0.140 |
Why?
|
Cyclophosphamide | 1 | 2023 | 2234 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2012 | 3635 | 0.140 |
Why?
|
Phosphorylation | 3 | 2014 | 8300 | 0.140 |
Why?
|
Doxorubicin | 1 | 2023 | 2228 | 0.140 |
Why?
|
Genomics | 3 | 2022 | 5924 | 0.130 |
Why?
|
Proteomics | 1 | 2009 | 3906 | 0.130 |
Why?
|
RNA Interference | 3 | 2014 | 2825 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11872 | 0.120 |
Why?
|
Cell Proliferation | 2 | 2012 | 10438 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5696 | 0.110 |
Why?
|
U937 Cells | 2 | 2012 | 259 | 0.100 |
Why?
|
HL-60 Cells | 2 | 2012 | 364 | 0.100 |
Why?
|
Hemoglobinopathies | 1 | 2013 | 101 | 0.100 |
Why?
|
Erythroid Precursor Cells | 1 | 2013 | 211 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1364 | 0.100 |
Why?
|
Cell Survival | 3 | 2012 | 5741 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2009 | 3605 | 0.090 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 3721 | 0.090 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2012 | 414 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2012 | 9521 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2782 | 0.080 |
Why?
|
Inhibitory Concentration 50 | 1 | 2009 | 463 | 0.080 |
Why?
|
Oxazines | 1 | 2009 | 358 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4566 | 0.070 |
Why?
|
Blotting, Western | 1 | 2014 | 5021 | 0.070 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13639 | 0.070 |
Why?
|
Galectin 3 | 1 | 2008 | 239 | 0.070 |
Why?
|
Morpholines | 1 | 2009 | 584 | 0.070 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 657 | 0.060 |
Why?
|
Aminopyridines | 1 | 2009 | 576 | 0.060 |
Why?
|
Mutation | 3 | 2024 | 30217 | 0.060 |
Why?
|
Tyrosine | 1 | 2009 | 1425 | 0.060 |
Why?
|
Mice, Inbred NOD | 1 | 2009 | 1837 | 0.060 |
Why?
|
Mice, SCID | 1 | 2009 | 2626 | 0.060 |
Why?
|
Drug Synergism | 1 | 2008 | 1755 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3403 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2009 | 1197 | 0.050 |
Why?
|
Quinazolines | 1 | 2009 | 1367 | 0.050 |
Why?
|
Small Molecule Libraries | 1 | 2008 | 739 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5509 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6105 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2825 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1377 | 0.050 |
Why?
|
Immunoglobulin Variable Region | 1 | 2022 | 419 | 0.050 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2023 | 647 | 0.050 |
Why?
|
Signal Transduction | 2 | 2014 | 23611 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12788 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7607 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2023 | 65201 | 0.040 |
Why?
|
Prognosis | 3 | 2024 | 29921 | 0.040 |
Why?
|
Humans | 11 | 2024 | 766351 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2888 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10740 | 0.040 |
Why?
|
Pyrimidines | 1 | 2009 | 3047 | 0.030 |
Why?
|
Models, Biological | 1 | 2013 | 9458 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8619 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4410 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11815 | 0.030 |
Why?
|
Time Factors | 2 | 2019 | 40112 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3664 | 0.020 |
Why?
|
Apoptosis | 1 | 2008 | 9507 | 0.020 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 83 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 17082 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22337 | 0.020 |
Why?
|
Immunomagnetic Separation | 1 | 2008 | 78 | 0.020 |
Why?
|
Receptors, CCR7 | 1 | 2008 | 105 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2565 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1876 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59527 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9333 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 335 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3282 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2024 | 81577 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22343 | 0.010 |
Why?
|
Male | 3 | 2024 | 363931 | 0.010 |
Why?
|
Mice | 1 | 2009 | 81863 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1647 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3795 | 0.010 |
Why?
|
Aged | 2 | 2024 | 171208 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24272 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 223092 | 0.010 |
Why?
|
Animals | 1 | 2009 | 168887 | 0.010 |
Why?
|
Female | 2 | 2024 | 396307 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 74825 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2008 | 20128 | 0.010 |
Why?
|
Adult | 1 | 2024 | 223220 | 0.010 |
Why?
|